Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Newborn Phosphatidylethanol Screening to Detect Fetal Alcohol Exposure in Uruguay

NCT02600624 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT02600624
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02600624 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Newborn Phosphatidylethanol Screening to Detect Fetal Alcohol Exposure in Uruguay
Lead sponsor
Northwestern University
Phase
Observational
Overall status
Completed
Start date
August 18, 2016
Completion date
July 31, 2019
Enrollment
1,412 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

fetal alcohol syndrome